Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Fontanilles

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancers|October 23, 2021
Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in GlioblastomaVianney Gilard, Justine Ferey, Florent Marguet, et al.
Oncotarget|June 22, 2017
Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphomaMaxime Fontanilles, Florent Marguet, Élodie Bohers, et al.
Radiation Oncology (London, England)|August 5, 2025
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective studyNicolas Goliot, Emmanuel Jouglar, Julian Jacob, et al.
Acta Neuropathologica Communications|April 19, 2020
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastomaMaxime Fontanilles, Florent Marguet, Philippe Ruminy, et al.
Breast Cancer Research : BCR|May 30, 2020
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancerFlorian Clatot, Anne Perdrix, Ludivine Beaussire, et al.
Neuro-Oncology Advances|June 10, 2024
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA NetworkInes Esparragosa Vazquez, Marc Sanson, Olivier L Chinot, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2020
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancerFlorian Clatot, Maxime Fontanilles, Laureline Lefebvre, et al.
Breast Cancer Research and Treatment|October 23, 2021
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancerPauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, et al.
The Journal of Investigative Dermatology|May 9, 2017
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel SequencingSylvain Mareschal, Anne Pham-Ledard, Pierre Julien Viailly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2025
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I StudyDinu Stefan, Paul Lesueur, Justine Lequesne, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancers|October 23, 2021
Integrative Metabolomics Reveals Deep Tissue and Systemic Metabolic Remodeling in GlioblastomaVianney Gilard, Justine Ferey, Florent Marguet, et al.
Oncotarget|June 22, 2017
Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphomaMaxime Fontanilles, Florent Marguet, Élodie Bohers, et al.
Radiation Oncology (London, England)|August 5, 2025
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective studyNicolas Goliot, Emmanuel Jouglar, Julian Jacob, et al.
Acta Neuropathologica Communications|April 19, 2020
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastomaMaxime Fontanilles, Florent Marguet, Philippe Ruminy, et al.
Breast Cancer Research : BCR|May 30, 2020
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancerFlorian Clatot, Anne Perdrix, Ludivine Beaussire, et al.
Neuro-Oncology Advances|June 10, 2024
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA NetworkInes Esparragosa Vazquez, Marc Sanson, Olivier L Chinot, et al.
European Journal of Cancer (Oxford, England : 1990)|January 14, 2020
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancerFlorian Clatot, Maxime Fontanilles, Laureline Lefebvre, et al.
Breast Cancer Research and Treatment|October 23, 2021
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancerPauline Corbaux, Audrey Lardy-Cleaud, Marie Alexandre, et al.
The Journal of Investigative Dermatology|May 9, 2017
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel SequencingSylvain Mareschal, Anne Pham-Ledard, Pierre Julien Viailly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2025
Olaparib, Temozolomide, and Concomitant Radiotherapy for Partially Resected or Biopsy-Only Glioblastoma First-Line Treatment: Results from the OLA-TMZ-RTE-01 Phase I StudyDinu Stefan, Paul Lesueur, Justine Lequesne, et al.
Pageof 3